Dr. Marcus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3685 Wheeler Rd
Suite 201
Augusta, GA 30909Phone+1 706-650-0061Fax+1 706-650-0064
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1990 - 1993
- Hackensack University Medical Center (Palisades)Internship, Transitional Year, 1987 - 1988
- Albert Einstein College of MedicineClass of 1987
Certifications & Licensure
- FL State Medical License 2023 - 2026
- IL State Medical License 2023 - 2026
- MA State Medical License 2023 - 2026
- GA State Medical License 1994 - 2025
- NY State Medical License 2023 - 2025
- SC State Medical License 1997 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MaximEyes SQL EHR, First Insight Corporation, 2012
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) Start of enrollment: 2011 May 01
- Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Clinical Performance of Semi-Automated Spectral-Domain Optical Coherence Tomography Angiography.A Yasin Alibhai, Mary K Durbin, Huiyuan Hou, Srinivas R Sadda, Dennis M Marcus
Journal of Clinical Medicine. 2024-10-22 - Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA.Charles C Wykoff, Diana V Do, W Lloyd Clark, David S Boyer, Dilsher S Dhoot
Ophthalmology. Retina. 2024-10-16 - Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial.Susan B Bressler, Abhijit Barve, Prasanna C Ganapathi, Katrin Beckmann, Rajendra S Apte
JAMA Ophthalmology. 2024-10-01
Press Mentions
- Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: